Transaction in Own Shares

Summary by AI BETAClose X

On October 8, 2025, GSK plc, acting through BNP Paribas SA, purchased 308,000 of its own ordinary shares with a nominal value of 31¼ pence each. The shares were bought at prices ranging from 1,612.00p to 1,630.00p, with a volume-weighted average price of 1,622.48p per share and will be held as Treasury shares. This purchase is part of an existing buyback program, bringing the total shares purchased since September 30, 2025, to 2,254,000. Following this transaction, GSK holds 249,718,844 ordinary shares in treasury, with 4,065,689,695 ordinary shares in issue excluding treasury shares, representing 6.14 percent of voting rights attributable to ordinary shares held in treasury. The total number of voting rights in the company is 4,065,689,695.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings